Skip Navigation

News & Resources

 

Subscribe to NHLBI Press Releases
September 12, 2016

Researchers Discover New Genetic Markers for Blood Pressure

WHAT: A team of researchers led by scientists from the Framingham Heart Study has discovered 31 new genetic markers it says are associated with blood pressure. The large-scale study provides new insight into the genetic underpinnings of high blood pressure and researchers say it could lead to better ways to treat the disease. Their study was published in Nature Genetics.

August 17, 2016

Study Shows Acetaminophen Can Be Tolerated by Young Children With Mild, Persistent Asthma

WHAT: In a study of children with mild, persistent asthma, scientists found that acetaminophen was tolerated without the worsening of asthma, when compared with ibuprofen use. The study, funded by the National Heart, Lung, and Blood Institute’s asthma network (AsthmaNet), appears in the August 18, 2016, issue of the New England Journal of Medicine.

Subscribe to NHLBI In The News
September 26, 2016 : HealthDay

Researchers are reporting new evidence that an increase in the amount of belly fat, especially “hidden fat” deep in the gut, is associated with a higher risk of developing heart disease.  The study also demonstrated that the density of stomach fat is as important as how much fat you have. In particular, the researchers found that lower density abdominal fat was associated with a higher risk for heart disease.  The six-year study included more than 1,000 adults.  It was published in the Journal of the American College of Cardiology and funded by the National Heart, Lung, and Blood Institute.

September 21, 2016 : The International Business Times

Smoking can permanently damage DNA in a way that contributes to the development of smoking-related illnesses, according to a new study. The findings could reveal an individual’s smoking history and help identify potential targets for therapy, the researchers note.  Their study is published in the journal Circulation: Cardiovascular Genetics, a publication of the American Heart Association. It was funded by the National Heart, Lung, and Blood Institute. 

September 26, 2016 to September 27, 2016
This workshop has two main objectives: (a) to assess recent developments in statistical methods relevant to NHLBI studies; (b) to identify the major challenges and important issues related to these statistical and analytical methods.
October 24, 2016 to October 25, 2016
Natcher Conference Center(Building 45) Bethesda, Maryland
The conference Unraveling Vascular Inflammation: From Immunology to Imaging 2016, sponsored by the National Heart, Lung and Blood Institutes (NHLBI) of the National Institutes of Health (NIH), seeks to convene scientists, researchers and physicians from around the world with an interest in immunology, human translational studies involving cardiovascular imaging and quantification. Hosted at the NIH campus, in Bethesda, MD, October 24 and 25, the day and a half conference will feature three keynote speakers (immunology, human inflammation and imaging), poster session and competition (including cash poster award and A High-Yield Series of Imaging Talks, a rapid fire series of 10 minutes talks by leading imaging scientists in the field.